Medtronic stock: Medtronic schedules November 17 results for Medtronic stock

Published on 10/20/2026 at 15:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 9.76 billion in fiscal first quarter 2027, up 13.70 percent. Medtronic stock costs EUR 83.71 on October 20, 2026, 0.75 percent below Xetra close.

Reporting date November 17, 2026

Medtronic's next earnings report is scheduled for November 17, 2026, before the US market opens.
Fiscal first-quarter revenue reached USD 9.76 billion, up 13.70 percent year over year.
Medtronic stock costs EUR 83.71 at Lang & Schwarz on October 20, 2026 at 3:36 p.m. CEST, 0.75 percent below the Xetra close of October 19, 2026.
Medtronic's market capitalization is USD 121.0 billion and its price-to-earnings ratio is 23.12.

Editorialfoto eines Trading-Floors mit Händlern und Kursdiagrammen im Hintergrund — Medtronic plc (ISIN IE00BTN1Y115) Börsen-Editorial zeigt Trading-Floor der NYSE mit Kursdiagrammen im Hintergrund lebhaft, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) has its next earnings report scheduled for November 17, 2026, before the US market opens, according to Gekko. The date gives investors a defined checkpoint after a period shaped by portfolio changes and solid reported growth. At Lang & Schwarz, the stock was trading at EUR 83.71 on October 20, 2026 at 3:36 p.m. CEST, down 0.75 percent versus the Xetra close of October 19, 2026 at EUR 84.34.

Revenue growth sets the baseline

Medtronic reported USD 9.76 billion of revenue for its fiscal first quarter of 2027, up 13.70 percent from the comparable period, while adjusted earnings per share reached USD 1.45 versus a USD 1.39 consensus estimate. The Stock Observer reported that the revenue figure exceeded the USD 9.55 billion estimate. The reporting period ended July 31, 2026.

Stock position and valuation

Medtronic's NYSE price was USD 94.59 on October 20, 2026 at 1:47 p.m. UTC, with a market capitalization of USD 121.0 billion and a price-to-earnings ratio of 23.12. The 52-week range was USD 73.31 to USD 106.33, placing the latest US price 11.07 percent below the high and 28.99 percent above the low. Trading volume reached 960,625 shares at that timestamp.

Dates and peer comparison

The next reporting date is November 17, 2026. Medtronic's quarterly dividend is USD 0.72 per share, according to The Stock Observer, which reported a 3.10 percent indicated yield and a September 25, 2026 ex-dividend date.

Comparison with peers

Medtronic plc: down 0.75 percent versus the Xetra close, price-to-earnings ratio 23.12, market capitalization USD 121.0 billion.

Abbott Laboratories (NYSE, USD): up 0.82 percent, price-to-earnings ratio 33.73, market capitalization USD 181.5 billion.

Stryker Corporation (NYSE, USD): up 1.61 percent, price-to-earnings ratio 31.23, market capitalization USD 116.1 billion.

What the November date adds

The November report will provide the next periodized test of whether the fiscal first-quarter revenue increase can continue. Until then, the stock's valuation remains lower than Abbott Laboratories' and Stryker Corporation's on the latest price-to-earnings figures, while Medtronic offers a separately reported quarterly dividend.

Medtronic was trading at EUR 83.71 at Lang & Schwarz on October 20, 2026 at 3:36 p.m. CEST, 0.75 percent below the Xetra close of October 19, 2026 at EUR 84.34. The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.